The Taiwan Food and Drug Administration (FDA) said Wednesday that it has issued a recall order for three blood pressure-lowering drugs, namely Exnortan, Daianxo, and Co-Daianxo, which were found to contain trace amounts of a carcinogen.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan chip sector urged to reduce reliance on China's rare earths
12/04/2025 10:25 PM - Society
Taiwan launches US$767 million program to boost 'medical resilience'
12/04/2025 09:57 PM - Business
Taiwan, Japan sign two deals on customs cooperation, digital trade
12/04/2025 09:18 PM - Cross-Strait
- Politics